.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Bladder cancer presents a clinical paradox where men suffer higher incidence but women face worse outcomes. However, recent advances in bladder cancer gene expression research now provide clarity on these differences. A study of 51 patients used transcriptome sequencing to compare tumor tissues with healthy mucosa. The results highlight a major divergence in how the disease manifests at a molecular level between sexes.
The research revealed that males have far more upregulated genes in tumor tissues compared to females. Specifically, the study identified 3,989 genes unique to male patients, while only 753 were unique to females. Male-specific expression patterns linked predominantly to cell cycle regulation and androgen receptor signaling. In contrast, female-specific patterns showed significant enrichment in immune-related pathways. These pathways include lymphocyte differentiation and leukocyte activation, which may influence how women respond to immunotherapy. Notably, overwhelmingly more upregulated genes appeared in male tissues than in female tissues during the comparison.
Notably, a two-factor interaction model pinpointed S100A14 as a critical sex-dependent gene. This protein-coding gene showed a significant interaction effect, suggesting it functions differently in male and female bladders. Furthermore, genes like GJB2 and DSC2 also showed probable sex-dependent interactions. These findings are essential because they provide a foundation for precision medicine. Therefore, doctors can potentially use these biomarkers to tailor surveillance and treatment plans more effectively. Indeed, the identification of these unique markers could pave the way for gender-specific therapeutic approaches.
Ultimately, this research underscores the necessity of considering biological sex in urological oncology. While clinicians currently use similar protocols for both genders, the molecular evidence suggests a need for sex-specific management. Future studies must validate these findings to improve survival rates and reduce recurrence for all bladder cancer patients.
Differences arise due to sex chromosomes, hormonal signaling, and distinct immune responses. These biological factors drive unique molecular pathways in tumor development, leading to different clinical presentations.
S100A14 is a protein-coding gene that exhibits a unique sex-dependent expression pattern. Researchers consider it a potential biomarker that could guide personalized treatment strategies in the future.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not be used for diagnosis or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Zeber-Lubecka N et al. Sex-related differences in gene expression in early-stage bladder cancer revealed by whole-transcriptome sequencing. BMC Cancer. 2026 Feb 09. doi: 10.1186/s12885-026-15666-3. PMID: 41663990.
Mun DH, Kimura S, Shariat SF, Abufaraj M. The impact of gender on oncologic outcomes of bladder cancer. Curr Opin Urol. 2019 Mar;29(2):279-285. doi: 10.1097/MOU.0000000000000606.
Yao R et al. Expression profile and functional role of S100A14 in human cancer. PeerJ. 2019 Apr 26;7:e6812. doi: 10.7717/peerj.6812.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study reveals sex-specific gene expression patterns in early-stage bladder cancer, highlighting the need for tailored management strategies for men and wo...
6 months ago
A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today
A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today
Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
